Dermatitis Herpetiformis

What is Dermatitis Herpetiformis?

Dermatitis herpetiformis (DH), sometimes called Duhring's disease, is a chronic, intensely itchy blistering skin rash that represents the cutaneous (skin) manifestation of celiac disease. It's often described as "celiac disease of the skin." The condition affects approximately 10-25% of people with celiac disease, though many people with dermatitis herpetiformis have minimal or no digestive symptoms, making the skin rash their primary or only sign of gluten sensitivity.

Despite its name, dermatitis herpetiformis has nothing to do with herpes viruses. The "herpetiformis" refers to the grouped or clustered appearance of the blisters, which resembles herpes skin lesions. The condition typically begins in adulthood, most commonly between ages 30-40, though it can occur at any age. It affects men slightly more often than women (ratio of about 3:2) and is more common in people of Northern European descent.

Symptoms and Clinical Presentation

The hallmark of dermatitis herpetiformis is an extremely itchy, burning, stinging rash with characteristic distribution and appearance:

Rash characteristics:

The rash appears as clusters of small, red bumps and tiny blisters (vesicles) that are intensely itchy. The itching is often described as burning or stinging and is typically out of proportion to the visible rash—many people scratch so intensely that they don't have intact blisters by the time they see a doctor, just scratch marks, excoriations, and scabs. The rash is usually symmetrical, appearing on both sides of the body in the same locations.

Typical locations:

The rash most commonly appears on the elbows (extensor surfaces), knees, buttocks, lower back and sacrum, back of the neck and scalp, shoulders, and along the hairline. Less commonly, it may affect the face, groin, or trunk. The distribution is highly characteristic and helps distinguish dermatitis herpetiformis from other blistering conditions.

Pattern and timing:

The rash tends to come and go, with periods of flare-ups and remission. Flares may be triggered by gluten consumption (though often with a delay of hours to days), iodine intake, stress, or without any identifiable trigger. Many people notice burning or intense itching before visible blisters appear. The rash can last for days to weeks during a flare, and new crops of blisters may continue to develop.

Associated symptoms:

While the skin manifestations dominate, some people with dermatitis herpetiformis also experience gastrointestinal symptoms similar to celiac disease, including bloating, abdominal pain, diarrhea, or constipation. However, many have no digestive complaints at all. Fatigue, headaches, and joint pain may also occur. Some people develop dental enamel defects, particularly if they had undiagnosed dermatitis herpetiformis during childhood when permanent teeth were forming.

Connection to Celiac Disease

Dermatitis herpetiformis is fundamentally the skin manifestation of celiac disease:

Nearly universal celiac disease association: Almost 100% of people with dermatitis herpetiformis have celiac disease based on small intestine biopsy findings, even if they have no digestive symptoms. The intestinal damage is present but may be patchy or milder than in people with classic celiac disease.

Shared immune mechanism: The same autoimmune process that causes intestinal damage in celiac disease also causes dermatitis herpetiformis. When people with genetic susceptibility consume gluten, their immune system produces IgA antibodies against tissue transglutaminase. In dermatitis herpetiformis, these IgA antibodies and related immune complexes deposit in the upper layer of the skin (papillary dermis), causing inflammation and the characteristic rash.

Genetic factors: Dermatitis herpetiformis is strongly associated with the same HLA-DQ2 and HLA-DQ8 genes that predispose to celiac disease. About 90% of people with dermatitis herpetiformis carry HLA-DQ2, and most of the rest carry HLA-DQ8.

Gluten as the trigger: Just like celiac disease, dermatitis herpetiformis is triggered by dietary gluten from wheat, barley, and rye. The rash improves or resolves completely with strict, lifelong gluten avoidance, confirming gluten as the causative factor.

Diagnosis

Diagnosing dermatitis herpetiformis requires specific testing because many other conditions can cause itchy, blistering rashes:

Skin biopsy (primary diagnostic test):

The gold standard for diagnosis is a skin biopsy showing characteristic IgA deposits in the papillary dermis (upper layer of skin). This is detected using a special technique called direct immunofluorescence (DIF). The biopsy should be taken from normal-appearing or slightly reddened skin immediately adjacent to a blister, not from the blister itself, as the diagnostic IgA pattern is best seen in uninvolved skin near active lesions. The pattern of granular IgA deposits along the dermal-epidermal junction is virtually diagnostic of dermatitis herpetiformis.

Blood tests:

Celiac antibody tests are usually positive, including tissue transglutaminase IgA (tTG IgA), endomysial antibody (EMA), and sometimes deamidated gliadin peptide (DGP) antibodies. However, some people with dermatitis herpetiformis have negative blood tests, so skin biopsy remains essential. Total IgA should be checked to ensure the person doesn't have IgA deficiency, which would make IgA-based tests unreliable. Some laboratories can measure epidermal transglutaminase antibodies (anti-TG3), which are specifically associated with dermatitis herpetiformis and may be positive even when other celiac antibodies are negative.

Small intestine biopsy:

Most people with dermatitis herpetiformis have intestinal changes consistent with celiac disease on small bowel biopsy, though the damage is often patchy or milder than in classic celiac disease. Some gastroenterologists recommend intestinal biopsy for all newly diagnosed dermatitis herpetiformis patients to document the extent of intestinal involvement and establish a baseline. However, others consider the characteristic skin biopsy findings sufficient for diagnosis and treatment, given the near-universal association with celiac disease.

Differential diagnosis:

Several other conditions can mimic dermatitis herpetiformis, including linear IgA disease (a related but distinct blistering disorder), bullous pemphigoid (an autoimmune blistering disease more common in elderly people), scabies (a parasitic infection), eczema or atopic dermatitis, and contact dermatitis. The characteristic distribution, direct immunofluorescence findings, and response to gluten-free diet help distinguish dermatitis herpetiformis from these conditions.

Treatment and Management

Treatment for dermatitis herpetiformis involves both dietary modification and sometimes medication:

Strict gluten-free diet (primary treatment):

The cornerstone of long-term treatment is complete, lifelong avoidance of gluten from wheat, barley, and rye. This is the same strict gluten-free diet required for celiac disease. The diet treats both the intestinal damage and the skin manifestations. However, the skin response to a gluten-free diet is slower than the intestinal response—while some people notice improvement within weeks, it typically takes several months to a year or more for the rash to completely resolve with diet alone. Even small amounts of gluten can trigger flares, so strict adherence is essential.

Dapsone (medication for symptom control):

Dapsone is a sulfone antibiotic with anti-inflammatory properties that dramatically improves the itching and rash of dermatitis herpetiformis, often within 24-48 hours. Most people notice significant relief within days of starting dapsone. It's typically prescribed at doses of 50-200 mg daily. Dapsone doesn't treat the underlying celiac disease or prevent intestinal damage—it only controls the skin symptoms. For this reason, it's used as a bridge therapy while the gluten-free diet takes effect, usually for several months to 1-2 years, then gradually tapered and discontinued as the diet provides adequate control.

Dapsone monitoring and side effects:

Before starting dapsone, blood tests must check glucose-6-phosphate dehydrogenase (G6PD) levels, as people with G6PD deficiency can have severe reactions to dapsone. Regular monitoring is required during treatment, including complete blood counts (CBC) to watch for anemia and methemoglobinemia, liver function tests, and reticulocyte counts. Common side effects include dose-related hemolytic anemia (red blood cell breakdown), methemoglobinemia (a blood disorder affecting oxygen-carrying capacity), headache, nausea, and peripheral neuropathy with long-term use. Most side effects are manageable with dose adjustment.

Alternative medications:

For people who cannot tolerate dapsone or have contraindications (such as G6PD deficiency), alternative medications include sulfapyridine (similar mechanism to dapsone but less commonly available) and sulfasalazine (though less effective than dapsone). Tetracycline antibiotics combined with niacinamide have been used with some success but are generally less effective than dapsone.

Iodine restriction:

Some people find that limiting dietary iodine helps reduce flares, as iodine can exacerbate dermatitis herpetiformis. This means avoiding iodine-rich foods like iodized salt, seafood, kelp and seaweed, and dairy products (which have variable iodine content). However, iodine restriction alone is not sufficient treatment—gluten avoidance remains essential.

Symptomatic relief:

While waiting for the gluten-free diet and medications to take full effect, symptomatic measures can help: antihistamines for itching (though often not very effective for DH), cool compresses on affected areas, gentle skin care avoiding harsh soaps and hot water, keeping nails trimmed to minimize damage from scratching, and loose-fitting clothing to reduce friction on affected areas.

Prognosis and Long-Term Outlook

The prognosis for dermatitis herpetiformis with proper treatment is excellent:

Rash improvement with gluten-free diet:

With strict gluten avoidance, the rash gradually improves over months to years. Most people can eventually discontinue dapsone while remaining rash-free on a gluten-free diet alone. However, even after years on a gluten-free diet, some people continue to have occasional small flares, particularly if they're inadvertently exposed to gluten.

Intestinal healing:

The intestinal damage from celiac disease improves with a gluten-free diet, typically healing within 6-24 months. This reduces risk of nutritional deficiencies, osteoporosis, and other celiac-related complications.

Lifelong condition:

Dermatitis herpetiformis is a chronic, lifelong condition. Even after the rash completely resolves on a gluten-free diet, returning to eating gluten will cause it to recur, often within days to weeks. The condition requires permanent gluten avoidance.

Variable course:

Some people achieve complete remission with diet alone and remain symptom-free for years or decades. Others require very low-dose dapsone (25-50 mg) long-term in addition to a strict gluten-free diet to maintain complete control. A small percentage of people have persistent symptoms despite strict dietary adherence and require ongoing medication.

Celiac disease complications:

Untreated dermatitis herpetiformis carries the same long-term risks as untreated celiac disease, including nutritional deficiencies (iron, vitamin D, calcium, B vitamins), osteoporosis, increased risk of other autoimmune diseases, small bowel lymphoma (rare but serious), and infertility or pregnancy complications. Following a strict gluten-free diet substantially reduces or eliminates these risks.

Quality of life:

With proper treatment, most people with dermatitis herpetiformis can achieve excellent quality of life. The intense itching resolves, skin heals (though some people have residual scarring from severe scratching), energy improves, and the risk of serious complications decreases. The main challenge is maintaining strict gluten avoidance lifelong, which requires vigilance but becomes routine over time.

Living with Dermatitis Herpetiformis

Dietary adherence:

Success depends on strict, permanent gluten-free diet adherence. This means reading all food labels carefully, being cautious about cross-contamination in kitchens and restaurants, and understanding hidden sources of gluten in processed foods, medications, and supplements. Working with a registered dietitian experienced in celiac disease is highly beneficial.

Monitoring:

Regular follow-up with a dermatologist and gastroenterologist is important. Annual blood tests to check celiac antibodies (to monitor dietary compliance), nutritional status (iron, vitamin D, B12, folate), and if on dapsone, regular monitoring for medication side effects are all part of ongoing care. Bone density screening may be recommended given the increased osteoporosis risk in celiac disease.

Support and resources:

Celiac disease and dermatitis herpetiformis support groups, either online or in-person, provide valuable practical advice, emotional support, and resources for living gluten-free. Many people find connecting with others who have the condition helpful for managing the challenges of lifelong dietary restrictions.

Pregnancy considerations:

Women with dermatitis herpetiformis can have healthy pregnancies. The condition doesn't directly affect fertility once gluten is eliminated and nutritional deficiencies are corrected. Continuing the gluten-free diet during pregnancy is essential, and some women may need to continue low-dose dapsone during pregnancy if the rash is severe, as uncontrolled inflammation may pose greater risk than low-dose medication.

Vaccination:

People with dermatitis herpetiformis should stay current on all recommended vaccinations, particularly pneumococcal vaccine and annual influenza vaccine, as celiac disease is associated with functional hyposplenism (reduced spleen function) in some individuals.